Home  /  Resource Library  /  Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea

Real-world experience with tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma in Korea

Real world study of CAR-T Tisagenlecleucel for treatment of DLBCL in Korea.